Translational Sciences Corporation (TSC) announced that it has received FDA 510(k) clearance for commercialization of its OncoTrac™ medical imaging software. OncoTrac™ is designed for efficient quantitative assessment of treatment response of metastatic tumors including breast, lung, colorectal...
Personalized medicine is about to get a much-needed kick start: The FDA has agreed to produce draft guidance documents that clarify and revise the standards by which companion diagnostics and biomarker qualifications are tested and approved. In a speech to the Personalized Medicine Coalition...
The University of Mississippi Medical Center will partner with the renowned Mayo Clinic on a series of initiatives intended to convert laboratory discoveries into new therapies and train a new generation of medical scientists. An agreement between the institutions, titled the Translational...